Pooled Human Red Blood Cells Lyophilized from Innovative Research are prepared from human whole blood that has been collected at an FDA-licensed facility located in the US. The red blood cells are separated from a solution of 1% dextran in whole blood via centrifugation and are not washed prior to lyophilization. A starting volume of approximately 5ml of red blood cells is used to create 1gm of lyophilized RBCs. 

Viral Testing

Each unit is tested for the standard FDA-required viral markers, and found negative for HBsAg, HCV, HIV-1, HIV-2, HIV-1Ag or HIV-1 NAT, ALT, West Nile Virus NAT, Zika NAT and syphilis using FDA-approved methods. When applicable a licensed NAT for Babesia has been performed and found to be non-reactive, if you would like any further testing or analysis performed prior to shipping, please let us know. While we make every effort to ensure the safety of our products, we recommend following universal precautions as laid out the following organizations WHO, CDC and OSHA, handle biological materials as if capable of spreading infectious disease. 

• Source: Human Whole Blood
• Format: Lyophilized Powder with Buffer Salts
• Appearance: Dark Red Powder
• Solubility: Clear Red Solution (1mg/ml saline)
• Storage: 2-8°C

Please note - this product replaces our old product number IR14011, Lyophilized Human Red Blood Cells/Erythrocytes (same product, new number).

This material is sold for in-vitro use only for manufacturing and research. This material is not suitable for human or animal use. While we make every effort to ensure the safety of our products, we recommend handling any biological materials with standard precautions as if capable of spreading infectious disease. The statements herin are offered for informational purposes only to be used solely for your consideration, investigation, and verification.

Please be aware the image pictured is for illustrative purposes only, and your product packaging and appearance may vary.

No Data Sheets available